Use of a VEGF antagonist to treat angiogenic eye disorders | Patent Number 11253572

US 11253572 B2
Application Number17352892
Publication NumberUS 20210308217 A1
Pendency8 months, 6 days
Filled DateJun 21, 2021
Priority DateJan 13, 2011
Publication DateOct 7, 2021
Expiration DateJan 12, 2031
Inventor/ApplicantsGeorge Yancopoulos
George YANCOPOULOS
ExaminesLOCKARD, JON MCCLELLAND
Art Unit1647
Technology Center1600
Assignments
Regeneron Pharmaceuticals
Current
Regeneron Pharmaceuticals
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.